Offers test artificial pancreas' hope for diabetes ~ Today's News

Researchers have used an "artificial pancreas" system of pumps and screens to improve blood sugar control in patients with diabetes in the first study to show the new device works better than conventional treatment.Researchers from Cambridge University in Britain to test the device in 17 children with type 1 diabetes during a series of nights in hospital and found that maintained their level of glucose in the important "normal" 60 percent of the time.The bodies of the victims of type 1 diabetes are unable to properly break down sugar, and if left untreated, blood vessels and nerves are destroyed, organs fail and patients die."These devices could transform the management of type 1 diabetes, but is probably a gradual process," Roman Hovorka of Cambridge, who led the research, said in a telephone interview.Researchers have used an "artificial pancreas" system of pumps and screens to improve blood sugar control in patients with diabetes in the first study to show the new device works better than conventional treatment.Researchers from Cambridge University in Britain to test the device in 17 children with type 1 diabetes during a series of nights in hospital and found that maintained their level of glucose in the important "normal" 60 percent of the time.The new system, which consists of patients who had a matchbox-size screens and a similar-sized pump with a hose to deliver insulin in the body, also halved the amount of sugar in the blood time was reduced to dangerous levels, worrisome, they said.He said the results were "a step" for the interposition of an artificial pancreas in the commercial market, but he predicted some years ago but refinement before it could be used day and night for patients with normal life."It's a bit like mobile phones. When we started, the technology was not very good, and the functionality is limited, and took a number of generations to go to the device you have now. I see the same thing with this system."He said the results were "a step" for the interposition of an artificial pancreas in the commercial market, but he predicted some years ago but refinement before it could be used day and night for patients with normal life."It's a bit like mobile phones. When we started, the technology was not very good, and the functionality is limited, and took a number of generations to go to the device you have now. I see the same thing with this system."The Juvenile Diabetes Research Foundation last month announced it had teamed with the United States Johnson & Johnson Pharmaceutical Animas unit, which makes insulin pumps, and DexCom Inc., which manufactures equipment for continuous glucose monitoring, developing and testing an artificial pancreas systems.Cambridge study, published in the medical journal The Lancet on Friday, use devices and sensors, Smiths Medical, a division of Smiths Group, Abbott Diabetes Care, a division of Abbott Laboratories and Medtronic.The ultimate goal is to create a device that can monitor patient's blood day and night, during and between meals, and deliver insulin as needed.Researchers have used an "artificial pancreas" system of pumps and screens to improve blood sugar control in patients with diabetes in the first study to show the new device works better than conventional treatment.